my face and eyes were swollen; my face and eyes were swollen; chest pain; Pericarditis; angioedema; swelling to my tongue; hives all over my body / continuous hives all over my body/urticaria; dose number=3; This is a spontaneous report received from a contactable reporter (Consumer or other non HCP). The reporter is the patient.  A 64-year-old female patient (not pregnant) received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), administered in arm left, administration date 01Dec2021 10:00 (Lot number: Fh8027) at the age of 64 years as dose 3 (booster), single for COVID-19 immunisation. Relevant medical history included: "Hyperlipidemia" (unspecified if ongoing); "osteoporosis" (unspecified if ongoing). Concomitant medications included: lovastatin (MANUFACTURER UNKNOWN). Vaccination history included: bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) (Dose Number: 1, Batch/Lot No: En6208, Location of injection: Arm Left, Vaccine Administration Time: 12:15 AM), administration date: 14Mar2021, when the patient was 63 years old, for COVID-19 immunization; bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) (Dose Number: 2, Batch/Lot No: Ew0150, Location of injection: Arm Left, Vaccine Administration Time: 11:45 AM), administration date: 04Apr2021, when the patient was 63 years old, for COVID-19 immunization. The following information was reported: SWOLLEN TONGUE (hospitalization, life threatening) with onset 02Dec2021 14:00, outcome "not recovered", described as "swelling to my tongue"; URTICARIA (hospitalization, life threatening) with onset 02Dec2021 14:00, outcome "not recovered", described as "hives all over my body / continuous hives all over my body/urticaria"; CHEST PAIN (hospitalization, life threatening) with onset 04Dec2021, outcome "not recovered", described as "chest pain"; PERICARDITIS (hospitalization, medically significant, life threatening) with onset 04Dec2021, outcome "not recovered", described as "Pericarditis"; ANGIOEDEMA (hospitalization, medically significant, life threatening) with onset 04Dec2021, outcome "not recovered", described as "angioedema"; SWELLING FACE (hospitalization, life threatening), EYE SWELLING (hospitalization, life threatening) all with onset 06Dec2021, outcome "not recovered" and all described as "my face and eyes were swollen"; IMMUNISATION (hospitalization, medically significant, life threatening) with onset 01Dec2021 10:00, outcome "unknown", described as "dose number=3". The patient was hospitalized for swollen tongue, urticaria, chest pain, pericarditis, angioedema, swelling face, eye swelling, immunisation (hospitalization duration: 2 days). The events "swelling to my tongue", "hives all over my body / continuous hives all over my body/urticaria", "chest pain", "pericarditis", "angioedema", "my face and eyes were swollen" and "my face and eyes were swollen" were evaluated at the emergency room visit. The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test (PCR): (04Dec2021) negative, notes: Nasal Swab. Therapeutic measures were taken as a result of swollen tongue, urticaria, chest pain, pericarditis, angioedema, swelling face, eye swelling which included steroids, famotidine (PEPCID), diphenhydramine hydrochloride (BENADRYL), colchicine, ibuprofen. Clinical course: The patient did not have COVID prior to vaccination. The patient did not have any known allergies. On 02Dec2021, the patient experienced swelling to her tongue and hives all over her body, treated with steroids in the emergency room (ER) and was sent home. On 04Dec2021, the patient had chest pain and went to the ER again. The patient was admitted for pericarditis, angioedema, and urticaria. On 06Dec2021, the patient's face and eyes were swollen with continuous hives all over my body.  Follow-up attempts are completed. No further information is expected.